Loading...
8 Respiratory System Drugs Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, Lupin, Zydus Group, Boehringer Ingelheim, GlaxoSmithKline
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Asia Pacific, Middle East and Africa, South America
Major Players: Boehringer Ingelheim, Merck, AstraZeneca, GlaxoSmithKline, Grifols
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: GlaxoSmithKline, Merck, AstraZeneca, Boehringer Ingelheim, Novartis
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Regeneron Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, Roche, Novartis
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: HEALIOS, Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeptico Forschung
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific
Major Players: Mayne Pharma, Hikma Pharmaceuticals, Lannett, GlaxoSmithKline, Teva Pharmaceutical Industries
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Merck, Koninklijke Philips, Fisher & Paykel Healthcare, Resmed, Hamilton Company
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Cipla, Boehringer Ingelheim, Roche, Fibrogen, Horizon Therapeutics
Filter Reports
By Region
By Countries
